Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Zebrafish models in neuropsychopharmacology and CNS drug discoveryKhan, Kanza M ; Collier, Adam D ; Meshalkina, Darya A ; Kysil, Elana V ; Khatsko, Sergey L ; Kolesnikova, Tatyana ; Morzherin, Yury Yu ; Warnick, Jason E ; Kalueff, Allan V ; Echevarria, David JBritish journal of pharmacology, 2017-07, Vol.174 (13), p.1925-1944 [Periódico revisado por pares]England: Blackwell Publishing LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Nanotechnology-based drug delivery for central nervous system disordersNguyen, Thuy Trang ; Dung Nguyen, Thi Thuy ; Vo, Tuong Kha ; Tran, Nguyen-Minh-An ; Nguyen, Minh Kim ; Van Vo, Toi ; Van Vo, GiauBiomedicine & pharmacotherapy, 2021-11, Vol.143, p.112117, Article 112117 [Periódico revisado por pares]France: Elsevier Masson SASTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Annona muricata (Annonaceae): A Review of Its Traditional Uses, Isolated Acetogenins and Biological ActivitiesMoghadamtousi, Soheil Zorofchian ; Fadaeinasab, Mehran ; Nikzad, Sonia ; Mohan, Gokula ; Ali, Hapipah Mohd ; Kadir, Habsah AbdulInternational Journal of Molecular Sciences, 2015-07, Vol.16 (7), p.15625-15658 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative diseaseHanson, Leah R ; Frey, 2nd, William HBMC neuroscience, 2008-12, Vol.9 Suppl 3 (S3), p.S5-S5, Article S5 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the ClinicVuillemenot, Brian R ; Korte, Sven ; Wright, Teresa L ; Adams, Eric L ; Boyd, Robert B ; Butt, Mark TToxicological sciences, 2016-07, Vol.152 (1), p.3-9 [Periódico revisado por pares]United StatesTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
The Blood-Brain Barrier: Bottleneck in Brain Drug DevelopmentPardridge, William M.NeuroRx, 2005, Vol.2 (1), p.3-14 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike propertiesWager, Travis T ; Hou, Xinjun ; Verhoest, Patrick R ; Villalobos, AnabellaACS chemical neuroscience, 2010-06, Vol.1 (6), p.435-449 [Periódico revisado por pares]United States: American Chemical SocietyTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Is Pharma Running Out of Brainy Ideas?MILLER, GREGScience (American Association for the Advancement of Science), 2010-07, Vol.329 (5991), p.502-504 [Periódico revisado por pares]United States: American Association for the Advancement of ScienceTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Active‐Site Concentrations of Chemicals – Are They a Better Predictor of Effect than Plasma/Organ/Tissue Concentrations?Hammarlund‐Udenaes, MargaretaBasic & clinical pharmacology & toxicology, 2010-03, Vol.106 (3), p.215-220 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
ADHD Drugs in Pregnancy Not Linked to Children’s Brain DevelopmentHarris, EmilyJAMA : the journal of the American Medical Association, 2023-03, Vol.329 (11), p.875-875 [Periódico revisado por pares]United States: American Medical AssociationTexto completo disponível |